pamidronate disodium for injection

indications

for ostealgia caused by hypercalcemia associated with malignancy and osteolytic bone metastases.

declaration:

the detailed prescription information of this product should be subject to confirmation by the latest approved version of the state food and drug administration.

the product information on this website is not for pharmaceutical advertising, but presented as product knowledge for the reference of professionals in the pharmaceutical industry only. it must not be used for the diagnosis of diseases, and it cannot replace medical advice provided by doctors or other qualified medical professionals.